Curriculum
Course Description:
Excipient composition may impact the critical quality attributes of biologics drug products and bring challenges to the excipient monograph Up-to-Date Initiative. USP aims to work closely with FDA and industry stakeholders in identifying a pathway for novel excipients not yet in approved drug products.
Featuring Thiago Carvalho, Ph.D., Member, USP Excipient Monographs 1 EC
Access Duration:Access to this course expires 60 days from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.